skip to main content

Andreas Peschel and Hans-Georg Rammensee Members of the Leopoldina

20.04.2023 CMFI News

The National Academy of Sciences Leopoldina has accepted Professors Andreas Peschel (Spokesperson of the Cluster of Excellence CMFI) and Hans-Georg Rammensee (Principal Investigator at CMFI) as members. Membership in the Leopoldina is an award for outstanding scientific achievements. The two new members from Tübingen of Class II - Life Sciences of the Leopoldina, were ceremoniously presented with their certificates by Leopoldina President Prof. Dr. Gerald Haug on 19.04 in Halle (Saale).

 

© Markus Scholz for Leopoldina
© Markus Scholz for Leopoldina

The new members of the Leopoldina Academy of Sciences are traditionally invited to the symposium of their specialist class the year after their election to receive their membership certificates. The members of the Leopoldina are to use their expertise to advise policy, engage with the public about scientific topics, and foster international relations. They follow the guiding principle "To explore nature for the benefit of mankind."

During the following scientific symposium Andreas Peschel and Hans-Georg Rammensee gave talks entitled “Antibiotic-resistant bacterial patogens and the microbiome” (Andreas Peschel) and “The peptides at the center of the immunological synapse: essential in health and disease” (Hans-Georg Rammensee).

 

The following members have been elected to Class II of the Leopoldina in 2022:

  • Andrea Ablasser, Lausanne/Switzerland, École Polytechnique Fédérale de Lausanne (EPFL) (Section microbiology and immunology)
  • Sonja-Verena Albers, Freiburg im Breisgau, Albert Ludwig University Freiburg (Genetics/molecular biology and cell biology)
  • Wulf Amelung, Bonn, University of Bonn (Section agricultural and nutritional sciences)
  • Michael Boutros, Heidelberg, German Cancer Research Center (DKFZ) of the Helmholtz Association (Section human genetics and molecular medicine)
  • Kai-Uwe Eckardt, Berlin, Charité – University Medicine Berlin (Section physiology und pharmacology/toxicology)
  • Ivo Feußner, Göttingen, University of Göttingen (Section organismic and evolutionary biology)
  • Robert Grosse, Freiburg im Breisgau, Albert Ludwig University Freiburg (Section physiology und pharmacology/toxicology)
  • Helmut Grubmüller, Göttingen, Max Planck Institute for Multidisciplinary Sciences (Section biochemistry and biophysics)
  • Claudia Höbartner, Würzburg, University of Würzburg (Section biochemistry and biophysics)
  • Katalin Karikó, Szeged/Ungarn, University of Szeged (Section human genetics and molecular medicine)
  • Andreas Peschel, Tübingen, University of Tübingen (Section microbiology and immunology)
  • Hans-Georg Rammensee, Tübingen, University of Tübingen (Section microbiology and immunology)
  • Tina Romeis, Halle (Saale), Leibniz Institute of Plant Biochemistry (Section organismic and evolutionary biology)
  • Rotem Sorek, Rehovot/Israel, Weizmann Institute of Science (Section genetics/molecularbiology and cell biology)
  • Alexandra Zoe Worden, Kiel, GEOMAR Helmholtz Centre for Ocean Research Kiel (Section organismic and evolutionary biology)

About the National Academy of Sciences Leopoldina

As the National Academy of Sciences, the Leopoldina provides independent science-based policy advice on socially relevant issues. To this end, the Academy prepares interdisciplinary statements based on scientific findings. These publications identify options for action; it is the task of democratically legitimized policymakers to decide. The experts who write statements work on an honorary basis and with an open mind. The Leopoldina represents German science in international bodies, including science-based advice for the annual G7 and G20 summits. It has 1,600 members from more than 30 countries and brings together expertise from almost all research fields. It was founded in 1652 and named Germany's National Academy of Sciences in 2008. As an independent academy of science, the Leopoldina is committed to the common good.

https://www.leopoldina.org/leopoldina-home/

Press Contact

Leon Kokkoliadis
Public Relations Management

Tel: +49 7071 29-74707
E-Mail: leon.kokkoliadis@uni-tuebingen.de

Looking for an expert?

Our CMFI PIs are experts in their fields. Please feel free to contact them directly.

CMFI Members

If you need help finding the right contact person, please reach out to us.

Related Articles

Clinical trial of innovative phage lysin HY-133 initiated
11.06.2024 Clinical trial of innovative phage lysin HY-133 initiated Press Release
"‘Raspberry Mineral’ Could Be Evidence Of Microbial Life On Early Earth And Other Worlds"
04.06.2024 "‘Raspberry Mineral’ Could Be Evidence Of Microbial Life On Early Earth And Other Worlds" In the Media

Forbes

"LuCa" project is funded by Else Kröner-Fresenius Foundation
16.05.2024 "LuCa" project is funded by Else Kröner-Fresenius Foundation CMFI News
“Medizinische Studien für vulnerable Personen: Medizinethiker Prof. Urban Wiesing”
16.05.2024 “Medizinische Studien für vulnerable Personen: Medizinethiker Prof. Urban Wiesing” In the Media

BR2

Iron-sulfur minerals bear witness to earliest life on earth
15.05.2024 Iron-sulfur minerals bear witness to earliest life on earth Press Release
Direkt in der Nase: Antimikrobielles Peptid bekämpft pathogene Bakterien
08.05.2024 Direkt in der Nase: Antimikrobielles Peptid bekämpft pathogene Bakterien Press Release
Andreas Peschel in the ARD podcast "Medizin von morgen" with Eckart v. Hirschausen and Katharina Adick
23.04.2024 Andreas Peschel in the ARD podcast "Medizin von morgen" with Eckart v. Hirschausen and Katharina Adick In the Media

ARD

Peter Loskill receives Ursula M. Händel Animal Welfare Prize from the DFG
16.04.2024 Peter Loskill receives Ursula M. Händel Animal Welfare Prize from the DFG CMFI News
Ruth Ley receives Advanced Grant from the European Research Council
11.04.2024 Ruth Ley receives Advanced Grant from the European Research Council Press Release
Podcast "Bakterien kontrollieren: Gute Bakterien nutzen, böse bekämpfen"
01.04.2024 Podcast "Bakterien kontrollieren: Gute Bakterien nutzen, böse bekämpfen" In the Media

Exzellent erklärt

Decoding new gene functions in the human gut microbiome
26.03.2024 Decoding new gene functions in the human gut microbiome CMFI News
DFG visits CMFI
20.03.2024 DFG visits CMFI CMFI News
Volkswagen Foundation funds project to convert waste into new biomaterials
14.02.2024 Volkswagen Foundation funds project to convert waste into new biomaterials CMFI News
Exploring hidden members in microbial communities
05.02.2024 Exploring hidden members in microbial communities CMFI News
Antibiotics highjack bacterial immunity
19.01.2024 Antibiotics highjack bacterial immunity Press Release
Novel antibiotic substance from the human nose
18.12.2023 Novel antibiotic substance from the human nose Press Release
Unraveling the Impact of Xenobiotics on Gut Microbiota: A High-Throughput Approach under Anaerobic Conditions
13.12.2023 Unraveling the Impact of Xenobiotics on Gut Microbiota: A High-Throughput Approach under Anaerobic Conditions In the Media
"Mikrobiom – Schlüssel zur Gesundheit?"
08.12.2023 "Mikrobiom – Schlüssel zur Gesundheit?" In the Media

Planet Wissen